# Randomised Arthroplasty Infection Worldwide Multidomain Adaptive Platform (ROADMAP) Trial

> **NCT06771050** · PHASE4 · NOT_YET_RECRUITING · sponsor: **University of Newcastle, Australia** · enrollment: 2500 (estimated)

## Conditions studied

- Prosthetic Joint Infections of Hip
- Prosthetic Joint Infections of Knee
- Large Joint Prosthetic Joint Infections

## Interventions

- **PROCEDURE:** Debridement and Implant Retention (DAIR)
- **DRUG:** Antibiotic Choice
- **DRUG:** Antibiotic duration Part A - Single stage revision
- **DRUG:** Antibiotic Duration Part B - Two stage revision

## Key facts

- **NCT ID:** NCT06771050
- **Lead sponsor:** University of Newcastle, Australia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03-26
- **Primary completion:** 2028-02-18
- **Final completion:** 2029-12-31
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2025-03-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06771050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06771050, "Randomised Arthroplasty Infection Worldwide Multidomain Adaptive Platform (ROADMAP) Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06771050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*